Literature DB >> 28973176

Association Between Poor Cognitive Functioning and Risk of Incident Parkinsonism: The Rotterdam Study.

Sirwan K L Darweesh1,2,3, Frank J Wolters1,2,3, Ronald B Postuma4, Bruno H Stricker5, Albert Hofman1,3, Peter J Koudstaal2, M Kamran Ikram1,2, M Arfan Ikram1,2,6.   

Abstract

Importance: Cognitive dysfunction is a common feature among patients with parkinsonism, including Parkinson disease (PD). However, there is a scarcity of data on cognitive functioning before parkinsonism diagnosis, a stage at which patients may still respond to putative disease-modifying interventions. Objective: To assess whether poor cognitive functioning is associated with an increased risk of parkinsonism. Design, Setting, and Participants: Between January 8, 2002, and December 14, 2008, baseline cognitive function was assessed in 7386 participants of the Rotterdam Study who were free of parkinsonism and dementia. Four tests were administered (Stroop color word test, letter-digit substitution, verbal fluency, and word learning) and a global cognition score was derived from principal component analysis. Subsequently, participants were followed up until January 1, 2015, for the onset of parkinsonism through serial in-person examinations and complete access to medical records. Parkinsonism was defined as the (1) presence of hypokinesia or bradykinesia plus at least 1 other cardinal sign and/or (2) clinical diagnosis by a neurologist or geriatrician. Patients with dementia diagnosis before parkinsonism diagnosis were considered to have probable PD. Main Outcomes and Measures: Hazard ratios (HRs) for incident parkinsonism per SD decrease in global cognition, adjusted for age, sex, and study subcohort.
Results: A total of 7386 patients were included in the analysis; of these, 4236 (57.4%) were women and mean (SD) age was 65.3 (10.2) years. During follow-up (median, 8.3 years; range, 0-15 years), 79 (1.1%) individuals received a diagnosis of incident parkinsonism; of these, 57 (72.2%) received a diagnosis of probable PD. Among patients with incident parkinsonism, 24 (30.4%) also developed dementia (10 before and 14 after parkinsonism onset). Poor global cognition at baseline was associated with a higher hazard of incident parkinsonism (hazard ratio [HR], 1.79; 95% CI, 1.37-2.33). The association remained robust beyond the first 8 years (HR, 1.59; 95% CI, 1.01-2.59) and after removing individuals with dementia onset before parkinsonism (HR, 1.72; 95% CI, 1.28-2.27). Poor global cognition at baseline was also associated with incident probable PD (HR, 1.52; 95% CI, 1.11-2.08). Letter-digit substitution (HR, 1.59; 95% CI, 1.22-2.04), verbal fluency (HR, 1.61; 95% CI, 1.23-2.08), and inverted interference task Stroop color word test (HR, 1.56; 95% CI, 1.25-1.96) scores were each associated with incident parkinsonism, whereas the association with word learning delayed-task scores was weaker (HR, 1.18; 95% CI, 0.92-1.52). Conclusions and Relevance: Poor cognitive functioning is associated with an increased risk of incident parkinsonism, including probable PD. Cognition indicates the probability of parkinsonism over long intervals and extends beyond patients with onset of parkinsonism after dementia. The findings suggest that cognitive dysfunction can be considered a sign of prodromal PD.

Entities:  

Mesh:

Year:  2017        PMID: 28973176      PMCID: PMC5822187          DOI: 10.1001/jamaneurol.2017.2248

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  36 in total

Review 1.  MDS research criteria for prodromal Parkinson's disease.

Authors:  Daniela Berg; Ronald B Postuma; Charles H Adler; Bastiaan R Bloem; Piu Chan; Bruno Dubois; Thomas Gasser; Christopher G Goetz; Glenda Halliday; Lawrence Joseph; Anthony E Lang; Inga Liepelt-Scarfone; Irene Litvan; Kenneth Marek; José Obeso; Wolfgang Oertel; C Warren Olanow; Werner Poewe; Matthew Stern; Günther Deuschl
Journal:  Mov Disord       Date:  2015-10       Impact factor: 10.338

2.  Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings.

Authors:  Lama M Chahine; Daniel Weintraub; Keith A Hawkins; Andrew Siderowf; Shirley Eberly; David Oakes; John Seibyl; Matthew B Stern; Kenneth Marek; Danna Jennings
Journal:  Mov Disord       Date:  2015-08-21       Impact factor: 10.338

Review 3.  Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment.

Authors:  Per Svenningsson; Eric Westman; Clive Ballard; Dag Aarsland
Journal:  Lancet Neurol       Date:  2012-08       Impact factor: 44.182

4.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.

Authors:  K A Welsh; N Butters; R C Mohs; D Beekly; S Edland; G Fillenbaum; A Heyman
Journal:  Neurology       Date:  1994-04       Impact factor: 9.910

5.  The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales.

Authors:  J F Fries; P W Spitz; D Y Young
Journal:  J Rheumatol       Date:  1982 Sep-Oct       Impact factor: 4.666

6.  Quantification of the completeness of follow-up.

Authors:  Taane G Clark; Douglas G Altman; Bianca L De Stavola
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

7.  Learning and retrieval rate of words presented auditorily and visually.

Authors:  N Brand; J Jolles
Journal:  J Gen Psychol       Date:  1985-04

Review 8.  Vascular parkinsonism--characteristics, pathogenesis and treatment.

Authors:  Amos D Korczyn
Journal:  Nat Rev Neurol       Date:  2015-04-28       Impact factor: 42.937

9.  CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.

Authors:  M Roth; E Tym; C Q Mountjoy; F A Huppert; H Hendrie; S Verma; R Goddard
Journal:  Br J Psychiatry       Date:  1986-12       Impact factor: 9.319

10.  Incident parkinsonism in older adults without Parkinson disease.

Authors:  Aron S Buchman; Sue E Leurgans; Lei Yu; Robert S Wilson; Andrew S Lim; Bryan D James; Joshua M Shulman; David A Bennett
Journal:  Neurology       Date:  2016-08-03       Impact factor: 9.910

View more
  21 in total

1.  Parkinson disease: What goes around comes around: cognitive impairment as prodromal parkinsonism?

Authors:  Yaroslau Compta; Maria J Martí
Journal:  Nat Rev Neurol       Date:  2017-11-10       Impact factor: 42.937

Review 2.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

Review 3.  The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

Authors:  Daniel Weintraub; Eugenia Mamikonyan
Journal:  Am J Geriatr Psychiatry       Date:  2019-03-09       Impact factor: 4.105

4.  Premature cognitive decline in specific domains found in young veterans with mTBI coincide with elder normative scores and advanced-age subjects with early-stage Parkinson's disease.

Authors:  Vicki A Nejtek; Rachael N James; Michael F Salvatore; Helene M Alphonso; Gary W Boehm
Journal:  PLoS One       Date:  2021-11-17       Impact factor: 3.240

Review 5.  Initial cognitive changes in Parkinson's disease.

Authors:  Daniel Weintraub; Alexander I Tröster; Connie Marras; Glenn Stebbins
Journal:  Mov Disord       Date:  2018-03-15       Impact factor: 10.338

6.  REM sleep behaviour disorder: an early window for prevention in neurodegeneration?

Authors:  Rimona S Weil; Huw R Morris
Journal:  Brain       Date:  2019-03-01       Impact factor: 13.501

7.  Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?

Authors:  Kurt A Jellinger; Amos D Korczyn
Journal:  BMC Med       Date:  2018-03-06       Impact factor: 8.775

8.  Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies.

Authors:  Giovanni Palermo; Eleonora Del Prete; Ubaldo Bonuccelli; Roberto Ceravolo
Journal:  J Neurol       Date:  2020-06-27       Impact factor: 4.849

Review 9.  Cognitive Impairment in Parkinson's Disease: Epidemiology, Clinical Profile, Protective and Risk Factors.

Authors:  Paulina Gonzalez-Latapi; Ece Bayram; Irene Litvan; Connie Marras
Journal:  Behav Sci (Basel)       Date:  2021-05-13

10.  Cognitive function in men with non-motor features of Parkinson's disease.

Authors:  Mario H Flores-Torres; Katherine C Hughes; Samantha Molsberry; Xiang Gao; Jae H Kang; Michael A Schwarzschild; Alberto Ascherio
Journal:  BMJ Neurol Open       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.